REDEFINING THE GLOBAL REGULATORY LANDSCAPE FOR ATMP COMMERCIAL APPROVAL: 1 APPROVAL TO RULE THEM ALL

Moderator:
Matthew Hewitt, Ph.D., Vice President, Technical Officer CGT and Biologics, Charles River Laboratories
Speakers:
Jean-Philippe Combal, Pharm.D., Ph.D., Co-founder and CEO, Vivet Therapeutics
Mike Lehmicke, Senior Vice President , Science and Industry Affairs, Alliance for Regenerative Medicine (ARM)
Devyn Smith, Ph.D., CEO, Arbor Biotechnologies; Chairman, Alliance for Regenerative Medicine (ARM)
Richard Wilson, Senior Vice President, Primary Focus Lead, Genetic Regulation, Astellas Pharma